Legacy Impactors

Product Details

Drug development is often costly, risky, and has a long payback cycle. Due to governmental and FDA pressure to reduce drug costs, many companies are implementing portfolios that include generics. The shortest and most cost-effective path to profitability in developing generics is to replicate existing methods.

While MSP, a Division of TSI, offers more efficient cascade impactors such as the NGI (with which most new drugs are developed), we provide many legacy cascade impactors and impingers as well. We are here to support the OINDP market in its pursuit of drug collection and characterization using equipment such as the MSLI, Marple Miller Impactor, Andersen Cascade Impactor, the Glass Twin Impinger, and others related to special USP and/or FDA guidelines for albuterol, FP/FPS, and many others.

Applications

• Aerodynamic particle size distribution (APSD) testing
• Inahlation drug delivery research
• Regulatory compliance testing (USP, FDA and others)
• Quality control and batch release testing
• Development of orally inhaled nasal drug products (OINDP)

Features and Benefits

• Proven accuracy and reliability
• Regulatory acceptance
• Durable and long-lasting
• Ease of maintenance and support
• Historical data integration